Nice to meet you

How a Digital innovation is possible in Healthcare System? Fabrizio Caranci, Global Digital Medicines Executive Director, explains how Angelini Pharma is promoting a digital culture between its people to take care of people.

Listen on Spreaker

Gabriele Ghirlanda, Global Access and Value Chief at Angelini Pharma, talks about his work and explains at what stage of drug development he intervenes, who are the key stakeholders with whom he interfaces, both inside and outside the company. He describes, as well, the process that leads pharmaceutical companies and Health Technology Assessment (HTA) bodies to determine the value of a drug and its price and how he can contribute to the aims of Angelini Parma to be “Every step closer” to people.

Listen on Spreaker

Agnese Cattaneo, explains what is the most interesting part of her job as Chief Medical Officer at Angelini Pharma and how the multinational pharmaceutical company compare with patients, considering that nowadays these are always more active, informed and involved in their therapeutic journeys. From to cure to care, she explains how is the role of Angelini Pharma in improving people’s quality of life and what are her personal expectations.

Listen on Spreaker

How does a drug idea come about? Rafal Kaminski, Chief Scientific Officer of Angelini Pharma, explains the main steps of the drug development process and the changes that are taking place as a result of technological progress.

Listen on Spreaker